Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Cash from Financing Activities (2016 - 2025)

Plus Therapeutics has reported Cash from Financing Activities over the past 16 years, most recently at $2.8 million for Q4 2025.

  • Quarterly Cash from Financing Activities changed N/A to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.3 million through Dec 2025, up 389.91% year-over-year, with the annual reading at $30.3 million for FY2025, 389.91% up from the prior year.
  • Cash from Financing Activities was $2.8 million for Q4 2025 at Plus Therapeutics, down from $12.3 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $12.4 million in Q1 2025 and troughed at -$776000.0 in Q1 2024.
  • The 5-year median for Cash from Financing Activities is $2.8 million (2025), against an average of $4.2 million.
  • Year-over-year, Cash from Financing Activities soared 51161.11% in 2021 and then crashed 634.34% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $9.2 million in 2021, then crashed by 98.92% to $99000.0 in 2022, then crashed by 634.34% to -$529000.0 in 2023, then surged by 1416.26% to $7.0 million in 2024, then tumbled by 59.74% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Cash from Financing Activities are $2.8 million (Q4 2025), $12.3 million (Q3 2025), and $2.8 million (Q2 2025).